ADALIMUMAB AND ANTI-DRUG ANTIBODIES IN A COHORT OF CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS: A SINGLE-CENTER EXPERIENCE

被引：0
|
作者：
Tarantino, G. [1 ]
Marafon, D. Pires [1 ]
Comitini, F. [2 ]
Simeoli, R. [3 ]
Aquilani, A. [1 ]
Nicolai, R. [1 ]
Marasco, E. [1 ]
De Benedetti, F. [1 ]
Magni-Manzoni, S. [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rheumatol, Rome, Italy
[2] Med Univ Hosp Cagliari, Paediat, Cagliari, Italy
[3] Bambino Gesu Pediat Hosp, Metab Dis Ctr, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Inflammatory arthritides; Targeted synthetic drugs; Outcome; measures;
D O I：
10.1136/annrheumdis-2023-eular.6465
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0777
引用
收藏
页码：680 / 680
页数：1
相关论文
共 50 条
  • [21] Systemic onset juvenile idiopathic arthritis: a single center experience
    Sag, Erdal
    Uzunoglu, Berna
    Bal, Fatma
    Sonmez, Hafize Emine
    Demir, Selcan
    Bilginer, Yelda
    Ozen, Seza
    TURKISH JOURNAL OF PEDIATRICS, 2019, 61 (06) : 852 - 858
  • [22] Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response
    Skrabl-Baumgartner, A.
    Erwa, W.
    Muntean, W.
    Jahnel, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2015, 44 (05) : 359 - 362
  • [23] Monitoring anti-drug antibodies to biological treatment in juvenile idiopathic arthritis: from protein to peptide-based assays
    Real Fernandez, Feliciana
    Rusche, Hendrik
    Marrani, Edoardo
    Peroni, Elisa
    Cimaz, Rolando
    Papini, Anna Maria
    Simonini, Gabriele
    Rovero, Paolo
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [24] Idiopathic fibrosing pancreatitis in children - a single-center experience
    Deshpande, Aniruddh V.
    LaHei, Erik R.
    Shun, Albert
    Martin, Hugh C. O.
    O'Loughlin, Edward V.
    JOURNAL OF PEDIATRIC SURGERY, 2006, 41 (12) : 1987 - 1991
  • [25] Factors that may influence the development of anti-drug antibodies to adalimumab
    Reinisch, W.
    Rauter, I.
    Chen, L.
    Gessner, M.
    Fanjiang, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S429 - S430
  • [26] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
    Reactions Weekly, 2018, 1701 (1) : 15 - 15
  • [27] EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS
    Schmeling, H.
    Horneff, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 71 - 71
  • [28] Temporomandibular joint involvement in children with juvenile idiopathic arthritis A single tertiary-center experience
    Alqanatish, Jubran T.
    Alrewaithi, Banan S.
    Alsewairi, Wafaa M.
    Khan, Altaf H.
    Alsalman, Mohammed J.
    Alrasheed, Abdulrhman A.
    SAUDI MEDICAL JOURNAL, 2021, 42 (04) : 399 - 404
  • [29] ADALIMUMAB SERUM DRUG LEVELS AND ANTI-DRUG ANTIBODIES: ASSOCIATION TO DISEASE ACTIVITY AND DRUG SURVIVAL IN INFLAMMATORY ARTHRITIS PATIENTS
    Jyssum, I.
    Gehin, J. E.
    Kristianslund, E.
    Sexton, J.
    Worren, D.
    Hu, Y.
    Kvien, T. K.
    Haavardsholm, E. A.
    Bolstad, N.
    Syversen, S. W.
    Goll, G. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 421 - 422
  • [30] Anti-Adalimumab Antibodies Kinetics: An Early Guide for Juvenile Idiopathic Arthritis (JIA) Switching
    Brunelli, Juliana
    Silva, Clovis A.
    Pasoto, Sandra G.
    Saad, Carla G. S.
    Kozu, Katia T.
    Leon, Elaine P.
    Vendramini, Margarete B.
    Fontoura, Nicole
    Bonfa, Eloisa
    Aikawa, Nadia E.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345